The CLARICOR study found that serum CTSB was associated with an increased risk of cardiovascular events in patients with stable coronary heart disease [42] and higher cathepsin activity along with an M2 macrophage phenotype was observed in carotid plaques from symptomatic patients [40]. Here, CTSB is linked to coronary artery disorder.